Comprehensive immunohistochemical analysis associated with the tumor microenvironment including monocarboxylate transporters in pancreatic ductal adenocarcinoma
Indian Journal of Pathology and Microbiology · 2025
DOI: 10.4103/ijpm.ijpm_739_24 ↗Kurz gefasst
Fachartikel in der Zeitschrift Indian Journal of Pathology and Microbiology, 2025. Verfasst von Duygu Akça und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pathology, Tekirdağ Dr. İsmail Fehmi Cumalıoğlu City Hospital, Tekirdağ, Turkey. Hauptthemen laut MEDLINE: Monocarboxylic Acid Transporters, Carcinoma, Pancreatic Ductal, Pancreatic Neoplasms, Tumor Microenvironment. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 45 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
Background/Aims: Pancreatic ductal adenocarcinoma is an aggressive neoplasm with poor prognosis. The metabolic properties of its desmoplastic stroma are hypothesized to contribute to disease progression. Aberrant metabolism in tumor cells and desmoplastic stroma results in the accumulation of metabolic by-products, with lactate being the most important, released into the extracellular space by monocarboxylate transporters (MCTs). This study aimed to determine the prognostic value of these markers and identify potential therapeutic targets. Study Design/Materials and Methods: Eighty-eight patients with Pancreatic adenocarcinomas (PDAC) were included. The tumoral and/or stromal expression of MCT1 , MCT4 , SMAD4 , vimentin, Ki67 , CD10 , and smooth muscle actin were investigated using the immunohistochemical analysis. Results/Conclusions: High MCT1 expression in tumor tissue was an independent prognostic marker for overall survival ( P < 0.01). Intense MCT1 expression in tumor tissue was associated with larger tumor size ( P < 0.05). Vimentin positivity and a higher Ki67 proliferation index were observed in the patients with lymphovascular invasion ( P < 0.05 and, P < 0.01, respectively). SMAD4 loss was higher in patients with metastasis ( P < 0.05). The overall survival was significantly reduced when the Ki67 proliferation index exceeded 50% ( P < 0.01). In conclusion, overexpression of MCT1 , a high Ki67 proliferation index, and loss of SMAD4 expression may serve as prognostic indicators of poor outcomes in PDAC. These findings hold the potential to guide the development of more effective therapeutic strategies for treating PDAC.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pathology, Tekirdağ Dr. İsmail Fehmi Cumalıoğlu City Hospital, Tekirdağ, Turkey.
- Department of Medical Oncology, Pamukkale University Hospital, Denizli, Turkey.
- Department of Pathology, Pamukkale University Hospital, Denizli, Turkey.
Zitieren
APA
Akça, D., Demiray, A. G., & Demirkan, N. (2025). Comprehensive immunohistochemical analysis associated with the tumor microenvironment including monocarboxylate transporters in pancreatic ductal adenocarcinoma. Indian Journal of Pathology and Microbiology. https://doi.org/10.4103/ijpm.ijpm_739_24
Vancouver
Akça D, Demiray AG, Demirkan N. Comprehensive immunohistochemical analysis associated with the tumor microenvironment including monocarboxylate transporters in pancreatic ductal adenocarcinoma. Indian Journal of Pathology and Microbiology. 2025. doi:10.4103/ijpm.ijpm_739_24
BibTeX
@article{Aka2025,
author = {Akça, Duygu and Demiray, Atike G and Demirkan, Neşe},
title = {Comprehensive immunohistochemical analysis associated with the tumor microenvironment including monocarboxylate transporters in pancreatic ductal adenocarcinoma},
journal = {Indian Journal of Pathology and Microbiology},
year = {2025},
doi = {10.4103/ijpm.ijpm_739_24}
}
EUVIMED